Skip to content

Kenvue to unveil two new products at PainWeek Conference

Kenvue Inc., the world’s largest pure-play consumer health company by revenue, announced Thursday that it will showcase new topical Tylenol Precise Pain Relieving Cream – the first U.S.

Table of Contents

SKILLMAN, N.J.  — Kenvue Inc., the world’s largest pure-play consumer health company by revenue, announced Thursday that it will showcase new topical Tylenol Precise Pain Relieving Cream – the first U.S. product launch from Kenvue since it became a publicly traded company – during the PAINWeek Conference 2023 on September 5-8 at The Cosmopolitan in Las Vegas, Nevada.

Kenvue will also feature another product newly launched this year, Motrin Dual Action with Tylenol, a fixed combination pill (containing 250 mg of acetaminophen and 125 mg of ibuprofen in each tablet) that provides dosing that supports up to 8 hours of pain relief compared with dosing provided by Tylenol Extra Strength or Motrin single ingredient products that can provide up to 6 hours of relief.

Both of these products come in response to consumer insights collected by Tylenol, the No. 1 Doctor Recommended Brand for Pain Relief.

When asked what consumers would change about their topical pain relief options, nearly 40% cited the unpleasant smell and the messy, greasy, or oiliness of current available products. Insights also showed 73% of consumers who use Tylenol® orally also use topical remedies, which identified a need for the brand to develop Tylenol Precise.

  • Tylenol Precise fits active lifestyles with a rapid-absorbing formula, fragrance-free and fresh scent options for discreet use, and a uniquely designed rollerball for hands-free, no-mess application leaving skin clear of sticky residues.
  • Both Tylenol Precise formats are skincare-inspired topical creams that provide maximum-strength lidocaine (4%) without a prescription.
  • In addition, Tylenol Precise Cooling Pain Relieving Cream has a light, pleasant scent so consumers can experience the dual action relief of lidocaine and menthol with an invigorating cooling sensation.

Motrin Dual Action with Tylenol, a fixed combination pill, provides dosing that supports up to 8 hours of pain relief.

  • By combining the strength and speed of two powerful pain relievers in one pill, Motrin Dual Action with Tylenol can provide a convenient alternative option for consumers.
  • Motrin  Dual Action with Tylenol® can provide longer-lasting relief than either brand taken alone, uniting the pain-targeting strength of Motrin  with the pain-blocking power of Tylenol.

“With Tylenol Precise we’re proud to deliver the topical formula our customers requested – one that fits their lifestyles by providing targeted pain relief both seamlessly and discreetly,” said Adam Ricciardone, Vice President, Kenvue Global Self-Care R&D. “We’re equally excited to introduce Motrin® Dual Action with Tylenol®, which for the first time unites the power of two major pain brands in one acetaminophen-ibuprofen pill. Our ability to launch these two important products in a single year is a testament to Kenvue’s extensive global expertise in both pain relief and skin care.”

Comments

Latest